Cuprina Holdings (Cayman) Limited (CUPR)
NASDAQ: CUPR · Real-Time Price · USD
5.82
-0.03 (-0.51%)
Jun 27, 2025, 4:00 PM - Market closed
Company Description
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name.
It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment.
The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
Cuprina Holdings (Cayman) Limited
| Country | Singapore |
| Founded | 2019 |
| IPO Date | Apr 10, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 14 |
| CEO | Yong Qi Quek |
Contact Details
Address: Blk 1090, Lower Delta Road #06-08 Singapore, 169201 Singapore | |
| Phone | 65 8512 7275 |
| Website | cuprina.com.sg |
Stock Details
| Ticker Symbol | CUPR |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | SGD |
| IPO Price | $4.00 |
| CIK Code | 0001995704 |
| ISIN Number | KYG2592E1026 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Yong Qi Quek | Chief Executive Officer and Director |
| Carl Marc Baptista | Founder, Chief Technology Officer and Director |
| Tat Jing Chan | Chief Financial Officer and Financial Controller |
| Dr. Naresh Waran Gnanasegaran | Head of Research & Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 4, 2025 | 6-K | Report of foreign issuer |
| May 14, 2025 | 20-F | Annual and transition report of foreign private issuers |
| May 8, 2025 | 6-K | Report of foreign issuer |
| May 8, 2025 | 6-K | Report of foreign issuer |
| May 5, 2025 | 6-K | Report of foreign issuer |
| Apr 17, 2025 | NT 20-F | Notification of inability to timely file Form 20-F |
| Apr 11, 2025 | 6-K | Report of foreign issuer |
| Apr 10, 2025 | 424B4 | Prospectus |
| Apr 9, 2025 | CERT | Certification by an exchange approving securities for listing |
| Apr 9, 2025 | 8-A12B | Registration of securities |